Post-hoc analyses of the recommended starting dose for Rytary based on “off” time
Objective: To determine whether correcting for “off” time duration improves the selection of the final LD dose when converting to extended-release carbidopa-levodopa capsules (ER CD-LD,…Decision-making process for opicapone’s bedtime regimen
Objective: To clarify the decision-making process for opicapone’s bedtime regímen. Background: OPC, a new once-daily COMT inhibitor, was shown to be effective in the treatment…Improving Clinical Trials Through Patient Input: Outcomes of a Partnership Between Pfizer and the Parkinson’s Disease Foundation
Objective: To identify the outcomes of the partnership between Pfizer and the Parkinson’s Disease Foundation (PDF), which was designed to 1. increase understanding of the…Evaluation of Brainstem Auditory Evoked Response and Nerve Conduction in Parkinson’s Disease
Objective: The Aim of our study was to evaluate Nerve Conduction Velocity & Brainstem Auditory Evoked Response in patients with Parkinson’s disease. Background: Parkinson’s disease is a progressive…Subcortical local shape volume analysis of progressive mild cognitive impairment in Parkinson`s disease
Objective: We evaluated the role of subcortical structures in ongoing dementia in Parkinson’s disease (PD). Background: Cortical neural correlates of ongoing cognitive decline in PD…Serotonin–to–dopamine transporter ratios in Parkinson’s dyskinesias: the longitudinal study
Objective: This study was designed to detect whether in Parkinson’s disease (PD) the putaminal serotonin–over–dopamine transporter ratio has a threshold that is critical for the…Striato-cortical connections in Parkinson’s and Alzheimer’s diseases: relation to cognition
Objective: To evaluate resting-state striato-cortical connectivity in PD and mild cognitive impairment due to Alzheimer's disease (AD-MCI) and assess their relation to cognitive outcomes. We…EEG Markers for Emotional Inhibition in Parkinson’s Disease
Objective: This study aims to advance understanding of neural mechanisms in Parkinson’s disease (PD) using event related potentials (ERPs) generated during emotional response inhibition and…Altered PDE10A Expression Detectable Early in Untreated Parkinson’s Disease Patients
Objective: To investigate in vivo whether loss of PDE10A expression in Parkinson’s disease (PD) is an early phenomenon in early untreated PD patients using positron…Central pain processing in “drug-naïve” pain-free patients with Parkinson’s disease
Objective: To investigate whether central pain processing is altered in “drug-naive” pain-free Parkinson disease (dnPD) patients. Background: Despite its clinical relevance, the pathophysiology of pain…
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 155
- Next Page »